A Review on the Reversal of the Old and New Anticoagulants. (October 2016)

• Record Type: Journal Article
• Authors: Bailey, Abby Mynatt; Blackburn, Matthew C.; Crowley, John M.; Horn, Kari S.; Schultz, Amy E.; Justice, Stephanie Baker
• Other Names: Weant Kyle A. section editor.
• Is Part Of: Advanced emergency nursing journal. Volume 38:Number 4(2016)
• Publication Date: 2016-10
• Subjects: anticoagulation -- apixaban -- bleeding -- dabigatran -- direct thrombin inhibitor -- edoxaban -- enoxaparin -- Factor Xa inhibitor -- low-molecular-weight heparin -- reversal -- rivaroxaban -- vitamin K antagonist -- warfarin; Emergency nursing -- Periodicals; Emergency medicine -- Periodicals; 616.02505
• DOI: 10.1097/TME.0000000000000123
• Languages: English
• ISSNs: 1931-4485

Abstract

Abstract : It is not uncommon for providers in the emergency department to take care of patients who are taking anticoagulant therapy in the outpatient setting. However, the bigger challenge is caring for these patients when they present with bleeding that could be secondary to 1 or more of these medications. In recent years, this class of medications has expanded from warfarin to include direct thrombin inhibitors and Factor Xa inhibitors. As this class of medications has evolved, so has the approach to the reversal of these agents. Thus, it is imperative that providers in the emergency department be familiar not only with the anticoagulants that patients may be taking in the outpatient setting but also with their reversal agents.